JPS5731619A - Improver for liver function - Google Patents

Improver for liver function

Info

Publication number
JPS5731619A
JPS5731619A JP10508180A JP10508180A JPS5731619A JP S5731619 A JPS5731619 A JP S5731619A JP 10508180 A JP10508180 A JP 10508180A JP 10508180 A JP10508180 A JP 10508180A JP S5731619 A JPS5731619 A JP S5731619A
Authority
JP
Japan
Prior art keywords
liver
improver
shark
extract
liver function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10508180A
Other languages
Japanese (ja)
Other versions
JPS6341889B2 (en
Inventor
Tetsuo Ikegawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP10508180A priority Critical patent/JPS5731619A/en
Publication of JPS5731619A publication Critical patent/JPS5731619A/en
Publication of JPS6341889B2 publication Critical patent/JPS6341889B2/ja
Granted legal-status Critical Current

Links

Abstract

PURPOSE: An improver for liver function having extremely low toxicity, usable continuously, comprising an extract of liver of a shark having a specific iodine value and a boiling point as an active ingredient.
CONSTITUTION: An improver for liver function comprising an extract of liver of a shark having an iodine value ≥385, preferably 385W395, and a boiling point ≥ about 350°C (30mmHg), preferably 350W370°C (30mmHg) as an active ingredient. The extract, for example, is obtained by taking out the liver of a shark, e.g., centrophorus of the family "Squalidae", etc., subjecting the content of the liver to fractional distillation, followed by treatment with a solvent. The improver is effective for remedying drug-induced hepatitis and viral hepatitis, and has extremely low toxicity. Especially oral administration is preferable, and its dose is 300W1,250mg per day in once to divided three times every day, depending upon the age and the condition of a patient.
COPYRIGHT: (C)1982,JPO&Japio
JP10508180A 1980-08-01 1980-08-01 Improver for liver function Granted JPS5731619A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10508180A JPS5731619A (en) 1980-08-01 1980-08-01 Improver for liver function

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10508180A JPS5731619A (en) 1980-08-01 1980-08-01 Improver for liver function

Publications (2)

Publication Number Publication Date
JPS5731619A true JPS5731619A (en) 1982-02-20
JPS6341889B2 JPS6341889B2 (en) 1988-08-19

Family

ID=14397972

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10508180A Granted JPS5731619A (en) 1980-08-01 1980-08-01 Improver for liver function

Country Status (1)

Country Link
JP (1) JPS5731619A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470574A (en) * 1986-08-21 1995-11-28 J. W. Broadbent Nominees Pty. Ltd. Active principle isolated from shark tissue

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470574A (en) * 1986-08-21 1995-11-28 J. W. Broadbent Nominees Pty. Ltd. Active principle isolated from shark tissue
US5632997A (en) * 1986-08-21 1997-05-27 J. W. Broadbent Nominees Pty. Ltd. Method of treating liver disfunction in mammals, using active principle isolated from shark tissue

Also Published As

Publication number Publication date
JPS6341889B2 (en) 1988-08-19

Similar Documents

Publication Publication Date Title
IE791806L (en) Gastroprotective mollusc extract
SE8001599L (en) TRANSDERMAL MEDICATION SYSTEM FOR ISOSORBID DINITRATE
JPS542316A (en) Solid pharmaceutical composition containing nifedipene
JPS5423115A (en) Gamma-globulin for intravenous injection and its preparation
JPS5731619A (en) Improver for liver function
JPS5218811A (en) Preparation of aqueous solution of fat- soluble substances
JPS5347515A (en) Gamma-globulin pharmaceutical preparation for intravenous injection
JPS5791922A (en) Antiviral agent of external use
JPS5793913A (en) Enhancing agent for spermous vital power
JPS57112331A (en) Medical composition of ganoderma lucidum component
JPS5746914A (en) Analgesic
JPS55122724A (en) Antidiabetic agent
JPS5618939A (en) Effective component in corbicula as a drug and its preparation
JPS5235227A (en) Preparation of filters for adhesives
JPS55154916A (en) Analgesic and anti-inflammatory agent
JPS5772917A (en) Drug having remedial action on hepatic disease and antihepatic cancer action
JPS5770818A (en) Remedy for hepatitis and its preparation
JPS5422365A (en) Isoxazole derivative, and antiseptic and sntifugal agnets for wood meterials comprising the derivativs as active constituent
JPS5241208A (en) Complete extraction of pharmaceutically active substances contained in mycelium and spores of "shiitake"
JPS5498339A (en) Carcinostatic agent
JPS56127312A (en) Drug for remedy of hepatic disease and recovery from fatigue
JPS5325534A (en) Mandelic acid glucosides and their anti-cancerous preparations
JPS5673027A (en) Preparation of antiphlogistic active substance
JPS5758630A (en) Interferon inducer
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives